Pinealon + Epitalon
Synergy Stack
The Russian longevity duo — two bioregulator peptides developed at the same institute by the same researcher, targeting the same gland through entirely different mechanisms.
Bioregulator Research
Addressed by This Stack
Per Year Protocol
🧬 What Is This Stack?
The Pinealon + Epitalon stack combines two synthetic peptide bioregulators developed at the St. Petersburg Institute of Bioregulation and Gerontology by Professor Vladimir Khavinson. Both are "Cytogens" — synthetic pineal-targeting peptides — but they work at entirely different levels of biology.
Neither compound alone covers the full anti-aging picture. Epitalon is powerful at the cellular/telomere level but doesn't directly address neural protection or the serotonin→melatonin conversion chain. Pinealon excels at neuroprotection and sleep architecture but doesn't directly activate telomerase. Together, they form the most complete pineal restoration protocol available in peptide bioregulation.
⚡ Why They Pair: Overlapping but Non-Redundant
Both peptides target the pineal gland, but through entirely different entry points. There is no mechanism redundancy — each covers what the other misses.
🔬 Epitalon
- Activates hTERT → telomere elongation
- Restores AANAT enzyme → melatonin
- Chromatin remodeling (epigenetic)
- IL-2 upregulation / immune modulation
- SOD antioxidant upregulation
- 12–13% max lifespan extension (mice)
🧠 Pinealon
- Upregulates 5-TPH → serotonin chain
- Suppresses caspase-3 → neuroprotection
- Recalibrates CLOCK, BMAL1, PER1/2 genes
- Indirect telomere protection via FNDC5/irisin
- SOD2 + GPX1 antioxidant activation
- MAPK/ERK, NMDA modulation
✅ Synergy
- Dual telomere protection
- Full melatonin chain
- Complete circadian reset
- Multi-layer neural protection
- Immune + neural aging
- Robust oxidative defense
The "Repair While You Sleep" Feedback Loop
This stack creates a positive feedback cycle where each compound amplifies the other's effects:
📊 Pathway Coverage by Compound
A direct comparison of which aging pathways each compound addresses — and where they overlap or complement each other:
| Pathway | Epitalon | Pinealon | Combined Effect |
|---|---|---|---|
| Telomerase / hTERT | ✅ Primary | ⚡ Indirect (irisin) | Dual telomere protection |
| Melatonin production | Via AANAT enzyme | Via 5-TPH → serotonin | Full synthesis chain covered |
| Circadian clock genes | Moderate modulation | ✅ Strong (CLOCK, BMAL1) | Complete circadian reset |
| Neuroprotection | Mild antioxidant upregulation | ✅ Primary (caspase-3) | Multi-layered neural defense |
| Immune modulation | ✅ IL-2, CD4/CD8 | Mild immune effects | Immune + neural aging addressed |
| Epigenetic remodeling | ✅ Chromatin structure | Direct DNA-promoter interaction | Broad gene expression normalization |
| Antioxidant systems | SOD upregulation | SOD2 + GPX1 activation | Robust oxidative defense |
🔬 Clinical Evidence
The evidence base for this stack draws primarily from Khavinson's research group at the St. Petersburg Institute, with growing independent Western replication for Epitalon.
Vladimir Khavinson published 775+ peer-reviewed papers and held 196 patents across 7 countries over 50 years. His death in January 2024 marked the end of an era. Both Pinealon and Epitalon have been used in Russian clinical settings for decades, though neither is FDA-approved. The evidence base is genuine but primarily from a single research tradition — large-scale Western RCTs do not yet exist.
Epitalon Evidence Highlights
Pinealon Evidence Highlights
🏛️ The Khavinson Research Lineage
Both compounds emerge from a single 50+ year scientific program — understanding this context is key to interpreting the evidence.
💉 Protocol & Dosing
Neither Pinealon nor Epitalon is FDA-approved for human therapeutic use. This information is for educational and research purposes only. Consult a qualified healthcare provider before use.
Standard Combined Protocol (10-Day Intensive)
| Compound | Daily Dose | Route | Timing | Duration |
|---|---|---|---|---|
| Epitalon | 5–10 mg | SubQ injection | Evening, 30–60 min before sleep | 10–20 days |
| Pinealon | 10 mg | Sublingual or SubQ | Morning (circadian alignment) | 10–20 days |
Cycle Frequency & Timing
Reconstitution Reference
Epitalon 10mg vial: Add 1 mL bacteriostatic water → 10 mg/mL. 10mg dose = 1.0 mL (full insulin syringe). 5mg dose = 0.5 mL.
Pinealon 10mg vial: Add 1 mL bacteriostatic water → 10 mg/mL. 10mg dose = 1.0 mL.
Storage: Reconstituted vials refrigerated (2–8°C), use within 28–30 days. Lyophilized powder at –20°C, stable 2+ years.
Supporting Supplements
| Supplement | Dose | Purpose | Timing |
|---|---|---|---|
| Magnesium Glycinate | 400–600mg | Sleep quality, GABA support | Evening |
| Vitamin B6 / P5P | 50mg | Serotonin→melatonin conversion cofactor | Evening |
| Vitamin D3 | 2000–5000 IU | Circadian signaling, immune function | Morning |
| Zinc | 15–30mg | Immune support, pineal function | Evening with food |
Most practitioners reduce or eliminate melatonin supplementation during active cycles. The point of this stack is to restore endogenous melatonin production — exogenous supplementation may create confounding feedback signals that blunt the therapeutic effect.
👥 Who Is This Stack For?
✅ Ideal Candidates
- Adults 40+ focused on longevity and healthy aging
- Declining sleep quality (less deep sleep, frequent awakenings)
- Cognitive concerns — brain fog, memory lapses
- Disrupted circadian rhythms from shift work or jet lag
- Family history of neurodegenerative disease (preventive)
- Bioregulator peptide enthusiasts seeking a complete stack
- Those wishing to reduce reliance on sleep medications
✗ Contraindications
- Active cancer of any type (telomerase concern)
- Pregnancy or breastfeeding
- History of hormone-sensitive cancers
- Concurrent SSRI/SNRI use (additive serotonin effects)
- Epilepsy or seizure disorders
- Active autoimmune conditions (without specialist guidance)
- Children or adolescents
Realistic Expectations
This is a long-game protocol, not a quick fix:
🧰 Expanding the Stack
This duo forms the pineal foundation of the broader "Russian Longevity Protocol." Common additions for a complete anti-aging program:
The bioregulator approach (restoring gene expression) and Western approaches (NAD+ support, senolytic clearance, mTOR modulation) are not mutually exclusive. Bioregulators restore the cell's regulatory program. NAD+ gives the mitochondria fuel to execute that program. Senolytics clear cells too damaged to respond to restoration. The Pinealon + Epitalon stack provides the foundational restoration layer that makes other interventions more effective.
❓ Frequently Asked Questions
Yes — the standard protocol runs them simultaneously for 10–20 days. Some practitioners prefer a sequential approach (Epitalon first for 10 days, then Pinealon for 10 days) on the theory that it allows each compound to "complete its signaling" without competition. However, there's no strong evidence favoring sequential over simultaneous use. The simultaneous approach is more common and more studied in the context of Russian bioregulator clinics.
This is the most important safety question for this stack. The 2025 Al-Dulaimi study specifically investigated this: in normal epithelial and fibroblast cells, telomere extension occurred via hTERT activation. In cancer cell lines, extension occurred via a separate pathway (ALT — Alternative Lengthening of Telomeres). Normal cells showed minimal ALT activity, suggesting the cancer-specific pathway doesn't activate inappropriately in healthy cells. However, since active telomerase could theoretically support cancer cell division, active cancer of any type remains an absolute contraindication. The decades-long Russian clinical use record has not documented increased cancer incidence, but long-term Western safety data is limited.
Pinealon is unusual among peptides in that oral bioavailability appears functional — it has been studied in oral form in human clinical trials. This is partly because its small tripeptide size (3 amino acids) makes it more resistant to digestive degradation than larger peptides. Sublingual delivery is generally preferred over swallowing for faster and more reliable absorption. Injectable SubQ offers the most predictable bioavailability. For optimal results, injectable or sublingual is recommended; oral capsules may serve as maintenance between cycles.
Melatonin supplementation is a downstream fix — replacing the output of a failing gland without addressing why it's failing. The Pinealon + Epitalon approach attempts to restore the pineal gland's own production capacity at the cellular and genetic level: Pinealon upregulates the serotonin→melatonin synthesis chain, while Epitalon restores AANAT enzyme activity and reduces pineal senescence via telomerase activation. The goal is a gland that produces its own melatonin in the correct circadian rhythm — which melatonin supplements can't achieve and can actually interfere with during cycles.
Both Pinealon and Epitalon are "Cytogens" — synthetic single-molecule peptides designed for fast-acting, targeted effects. Their natural multi-peptide counterparts are Cytomaxes: Endoluten (natural bovine pineal extract) is the Cytomax for Epitalon's target tissue. Standard Khavinson clinical usage is: use Cytogen (Pinealon/Epitalon) for the active treatment cycle, then maintain with the corresponding Cytomax (Endoluten) every 3 months. Cytomaxes have slower onset but longer-lasting effects (6+ months) vs. Cytogens which act faster but for shorter duration.
🛒 Recommended Products
Supplies and supplements commonly used with this protocol. Affiliate links support MeetPeptide at no extra cost.
Affiliate links help support MeetPeptide at no extra cost to you.
🔗 Related Resources
This page is for educational and informational purposes only. Neither Pinealon (EDR/Glu-Asp-Arg) nor Epitalon (AEDG/Ala-Glu-Asp-Gly) is approved by the FDA or any Western regulatory body for human therapeutic use. The information presented reflects published research and community protocols — it does not constitute medical advice and should not be used to make clinical decisions. Always consult a qualified healthcare provider before starting any peptide protocol. The evidence base for these compounds comes primarily from a single research tradition (Khavinson group); large-scale Western RCTs are limited or absent.